005 |
|
060113110520.0 |
010 |
|
|a2005040638
|
020 |
|
|a0123693705 (alk. paper)
|
040 |
|
|aTWNTU|cTWNTU|dTWNTU
|
041 |
|
|aeng
|
050 |
0
|
|aHD9999.B442|bB542 2005
|
082 |
14
|
|a174.96606|bB52
|
095 |
|
|a臺東大學|bG|cE040096|d174.96606|eB615|pBOOK|fCHIPPER|zBOOK|m0|tDDC
|
245 |
10
|
|aBioIndustry ethics /|cDavid L. Finegold ... [et al.].
|
260 |
|
|aBoston, Mass. :|bElsevier Academic Press,|c2005.
|
300 |
|
|axi, 368 p. ;|c23 cm.
|
504 |
|
|aIncludes bibliographical references and index.
|
650 |
0
|
|aPharmaceutical industry|xMoral and ethical aspects|vCase studies.
|
650 |
0
|
|aBusiness ethics|xMoral and ethical aspects|vCase studies.
|
650 |
0
|
|aBiotechnology industries|xMoral and ethical aspects|vCase studies.
|
700 |
1
|
|aFinegold, David.
|
809 |
|
|d174.96606|eB615|tDDC|pBOOK
|